subscribe
 

Next step towards replacement therapy in type 1 diabetes

Scientists have discovered the signals that determine the fate of immature cells in the pancreas



Metabolism stress test kits

Evaluation of the glycolytic response of in vitro cell models to metabolic stress



Study explains the link between cilia and diabetes

Latest research finds that cilia play a key role in insulin release



Anti-diabetic drug slows ageing effects

Researchers tease out the mechanism behind metformin’s age-slowing effects



Mother’s genes work with baby’s to prevent obesity

Scientists uncover how copies of a gene present in both mother and baby interact to control optimal growth of the child



EKF Diagnostics launches ß-Hydroxybutyrate strip test

STAT-Site M ß-HB will be premiered at Booth #3614 at the American Association for Clinical Chemistry’s Annual Meeting and Clinical Lab Expo in Houston, 30th July to 1st August.



Alize Pharma launches the first Phase I clinical trial for AZP-531

The Medicine and Healthcare Regulatory Authority (MHRA) has granted authorization to conduct a trial in the UK on AZP-531 in healthy volunteers, obese subjects and diabetic patients.



New research provides insights into the ability of muscles to take in glucose

New studies conducted by a Danish research group from University of Copenhagen have identified a molecule which can explain why blood sugar regulation functions poorly in patients with type 2 diabetes and why exercise increases the body's ability to take in glucose.



EKF showcases novel end stage renal disease test at ADA 2013

EKF Diagnostics, the global point-of-care diagnostics business, will showcase a novel test to accurately identify diabetic patients at high risk of progression to end stage renal disease (ESRD) up to 10 years in advance of currently available tests.



Healthcare deficiencies for people with intellectual disability

Deficiencies in healthcare and inadequate health promotion are just two of the causes of health inequalities for people with intellectual disability



Lonza launches 2013-2014 BioResearch Catalog

Diabetes prevention has become a key focus area for the drug development market.



Diabetes: double trouble – its effects on heart and brain

Scientists at the University of Sheffield are launching a pioneering investigation to discover how diabetes affects heart and brain function in order to help the soaring number of people living with the disease.



Liver inflammation raises cholesterol levels

Inflammatory processes that are known to occur in many metabolic disorders such as type 2 diabetes and obesity and contribute significantly to long-term complications



Monitoring HbA1c in diabetes patients

European Reference Laboratory for Glycohemoglobin study reaffirms EKF’s Quo-Test meets HbA1c performance criteria



Heart disease, high blood pressure and diabetes may combine to worsen thinking skills

Preventing or delaying cardiovascular disease or diabetes may delay cognitive decline and possible dementia



Growing levels of diabetes threatens NHS, warns leading academic

Government must act now to prevent further escalation of childhood obesity



Scientists discover link between bacteria and supposedly non-infectious diseases

Discovery could help to explain many features of diseases, including Alzheimer's, Parkinson's and diabetes, and may lead to new methods of prevention or treatment



Receptor discoveries pave the way for new drugs to treat metabolic diseases

New structural information obtained with the help of intense X-rays has enabled scientists to solve the high-resolution X-ray crystal structure of the glucagon receptor



Stevia: the fast growing alternative to sugar

Natural sweetener derived from a plant native to Central and South America



Pages

Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe